Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer.
Saved in:
| Title: | Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer. |
|---|---|
| Authors: | van Veggel, B.1 (AUTHOR), Madeira R Santos, J.F. Vilacha2 (AUTHOR), Hashemi, S.M.S.3 (AUTHOR), Paats, M.S.4 (AUTHOR), Monkhorst, K.5 (AUTHOR), Heideman, D.A.M.6 (AUTHOR), Groves, M.2 (AUTHOR), Radonic, T.6 (AUTHOR), Smit, E.F.1 (AUTHOR), Schuuring, E.7 (AUTHOR), van der Wekken, A.J.8 (AUTHOR), de Langen, A.J.1 (AUTHOR) j.d.langen@nki.nl |
| Source: | Lung Cancer (01695002). Mar2020, Vol. 141, p9-13. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2019.12.013 |
